A PEPTIDE DIFFERENCE BETWEEN THE MU-CHAINS FROM CELL-ASSOCIATED AND SECRETED IGM OF THE BCL1 TUMOR

被引：0
|
作者：
YUAN, D
UHR, JW
VITETTA, ES
机构：
来源：
JOURNAL OF IMMUNOLOGY | 1980年 / 125卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：40 / 46
页数：7
相关论文
共 10 条
  • [1] DETECTION OF UNIQUE PEPTIDES DERIVED FROM THE MU-CHAINS OF CELL-SURFACE BUT NOT SECRETED IGM
    YUAN, D
    UHR, JW
    VITETTA, ES
    MOLECULAR IMMUNOLOGY, 1981, 18 (06) : 467 - 471
  • [2] MU-CHAINS FROM A NONSECRETOR B-CELL LINE DIFFER FROM SECRETED MU-CHAINS AT C-TERMINAL END
    WILLIAMS, PB
    KUBO, RT
    GREY, HM
    JOURNAL OF IMMUNOLOGY, 1978, 121 (06): : 2435 - 2439
  • [3] AN INVITRO LINE OF THE B-CELL TUMOR BCL1 CAN BE ACTIVATED BY LPS TO SECRETE IGM
    GRONOWICZ, ES
    DOSS, CA
    HOWARD, FD
    MORRISON, DC
    STROBER, S
    JOURNAL OF IMMUNOLOGY, 1980, 125 (03): : 976 - 980
  • [4] LPS-INDUCED DIFFERENTIATION OF A MURINE B-CELL LEUKEMIA (BCL1) - CHANGES IN SURFACE AND SECRETED-IGM
    LAFRENZ, D
    KORETZ, S
    STRATTE, PT
    WARD, RB
    STROBER, S
    JOURNAL OF IMMUNOLOGY, 1982, 129 (03): : 1329 - 1335
  • [5] STRUCTURAL DIFFERENCES BETWEEN U CHAINS FROM CELL-SURFACE AND SECRETED IGM
    YUAN, D
    UHR, JW
    KNAPP, M
    SLAVIN, S
    STROBER, S
    VITETTA, ES
    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, : 257 - 257
  • [6] CHARACTERIZATION OF A SPONTANEOUS MURINE B-CELL LEUKEMIA (BCL1) .2. TUMOR-CELL PROLIFERATION AND IGM SECRETION AFTER STIMULATION BY LPS
    KNAPP, MR
    SEVERINSONGRONOWICZ, E
    SCHRODER, J
    STROBER, S
    JOURNAL OF IMMUNOLOGY, 1979, 123 (03): : 1000 - 1006
  • [7] PRODUCTION OF A B-CELL GROWTH-PROMOTING ACTIVITY, (DL)BCGF, FROM A CLONED T-CELL LINE AND ITS ASSAY ON THE BCL1 B-CELL TUMOR
    SWAIN, SL
    DUTTON, RW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (06): : 1821 - 1834
  • [8] INDUCTION OF TUMOR-IMMUNITY BY INTACT IRRADIATED LEUKEMIC B-CELLS (BCL1) BEARING A TUMOR-ASSOCIATED CELL-SURFACE IDIOTYPE AND THE COSTIMULATORY B7 MOLECULE
    MORECKI, S
    LEVI, S
    PUYESKY, Y
    SLAVIN, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (04) : 236 - 242
  • [9] Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and antiprogrammed cell death-1 antibody therapies
    Yokota, Chisato
    Nakata, Jun
    Takano, Koji
    Nakajima, Hiroko
    Hayashibara, Hiromu
    Minagawa, Hikaru
    Chiba, Yasuyoshi
    Hirayama, Ryuichi
    Kijima, Noriyuki
    Kinoshita, Manabu
    Hashii, Yoshiko
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Oji, Yusuke
    Kumanogoh, Atsushi
    Sugiyama, Haruo
    Kagawa, Naoki
    Kishima, Haruhiko
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [10] Identification of CD4+ T cell epitopes from human melanoma associated tumor antigens TRP-1 and TRP-2 based upon immunization of HLA-class II transgenic mice with recombinant adenovirus and combinatorial peptide library screening in vitro
    Osen, W.
    Song, M.
    Soltek, S.
    Steitz, J.
    Tueting, T.
    Leuchs, B.
    Ngyuen, X. D.
    Schadendorf, D.
    Paschen, A.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 298 - 298
1